Navigation Links
Gourmetceuticals to Present Data from Four Studies at Experimental Biology 2008
Date:3/26/2008

Poster Presentations Highlight Potential Uses of Gourmetceuticals'

Functional Ingredients GLPH-1(TM) and PPL-240(TM)

BIG HORN, Wyo., March 26 /PRNewswire/ -- Gourmetceuticals, LLC, a company that markets organically derived and scientifically validated ingredients for use in foods and beverages, today announced that multiple studies of Gourmetceuticals' ingredients, GLPH-1, an immune booster, and PPL-240, an antioxidant, will be presented at the Experimental Biology 2008 conference in San Diego, April 5-9, 2008 in the exhibit hall of the San Diego Convention Center. Data will be presented from clinical studies intended to highlight the clinical benefits of GLPH-1 and PPL-240 for use in functional foods and beverages.

Photoprotective Antioxidant PPL-240(TM) Poster Presentation

April 6, 2008, 1:00 - 2:15 p.m., Abstract Title: Polypodium leucotomos extract, PPL-240, prevents solar-induced DNA damage in human peripheral blood mononuclear cells

Poster Title: Apoptosis and Cell Stress (Poster Number: A414)

Immune Booster GLPH-1(TM) Poster Presentations

April 8, 2008, 12:15 - 1:30 p.m., Abstract Title: The presence of an alpha glucomannan polysaccharide, GLPH-1, (IF-S) activates NFkB and p38 in hMDDC

Poster Title: Chemistry and Cell Biology of Natural Products (Poster Number: A466)

April 8, 2008, 12:15 - 1:30 p.m., Abstract Title: IF-S, a phosphorylated alpha glucomannan polysaccharide, GLPH-1, induces functional human dendritic cell maturation

Poster Title: Chemistry and Cell Biology of Natural Products (Poster Number: A465)

April 8, 2008, 1:45 - 2:45 p.m., Abstract Title: Experimental animal model study of diet supplementation with phosphorylated alpha glucomannan polysaccharide, GLPH-1

Poster Title: Experimental Animal Nutrition (Poster Number: C304)

About Functional Foods

Functional foods are foods and beverages with claimed health benefits based on scientific evidence. The field of functional foods is an emerging field in the food science industry and is composed of the foods that contain scientifically validated ingredients that provide a health benefit above the benefit of the food itself. The market is growing exponentially with a projected growth from $25 billion in 2006 to $39 billion by 2011.

About Gourmetceuticals

Gourmetceuticals, LLC is a research-based culinary technology company that markets organically derived and scientifically tested ingredients for use in foods and beverages. Its ingredients, GLPH-1(TM) and PPL-240(TM), can transform human and veterinary products into gourmet functional foods and are FDA approved for human and animal consumption, GRAS affirmed, kosher and meet current Good Manufacturing Practices (cGMP) as outlined by the FDA. GLPH-1 is a polysaccharide extract from botanical yeast that promotes immune health and PPL-240 is an antioxidant derived from a South American fern that has been shown clinically to reduce damage from UVA and UVB rays. Both ingredients have been subject to more than 20 clinical trials that evaluated and supported their safety and effectiveness in humans and animals. For more information, visit the Company Web site at http://www.gourmetceuticals.com.


'/>"/>
SOURCE Gourmetceuticals, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
5. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
6. AtriCure to Present at Roth Capital Partners 2007 New York Conference
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. MDS to Present at Thomas Weisel Partners Healthcare Conference
9. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
10. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has issued an ... extreme heat at their worksites. Employers with workers exposed to high temperatures ...
(Date:6/27/2016)... ... 27, 2016 , ... "FCPX editors can now reveal their media with growing ... said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings ... users can now reveal the media of their split screens with growing colorful panels. ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... cutting edge technology to revolutionize the emergency ambulance transport experience for the millions ... aware of how Uber has disrupted the taxi industry through the use of ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... SYDNEY , June 26, 2016 One of ... , has announced the formation of a new biotechnology company, Noxopharm ... raise $6m in an IPO and to list on the ASX. ... drug candidate, NOX66, ready to enter a Phase 1 clinical study ... been designed to address one of the biggest problems facing cancer ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: